Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 186

1.

Biopharmaceuticals for rheumatic diseases in Latin America, Europe, Russia, and India: Innovators, biosimilars, and intended copies.

Castañeda-Hernández G, Szekanecz Z, Mysler E, Azevedo VF, Guzman R, Gutierrez M, Rodríguez W, Karateev D.

Joint Bone Spine. 2014 Jun 20. pii: S1297-319X(14)00099-2. doi: 10.1016/j.jbspin.2014.03.019. [Epub ahead of print]

PMID:
24956990
[PubMed - as supplied by publisher]
2.

Impaired endothelial function in patients with undifferentiated connective tissue disease: a follow-up study.

Laczik R, Soltesz P, Szodoray P, Szekanecz Z, Kerekes G, Paragh G, Rajnavölgyi E, Abel G, Szegedi G, Bodolay E.

Rheumatology (Oxford). 2014 Jun 10. pii: keu236. [Epub ahead of print]

PMID:
24917564
[PubMed - as supplied by publisher]
3.

Effects of laser treatment on the expression of cytosolic proteins in the synovium of patients with osteoarthritis.

Barabás K, Bakos J, Zeitler Z, Bálint G, Nagy E, Lakatos T, Kékesi AK, Gáspár L, Szekanecz Z.

Lasers Surg Med. 2014 Jun 7. doi: 10.1002/lsm.22268. [Epub ahead of print]

PMID:
24909318
[PubMed - as supplied by publisher]
4.

Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment.

Choy E, Ganeshalingam K, Semb AG, Szekanecz Z, Nurmohamed M.

Rheumatology (Oxford). 2014 Jun 6. pii: keu224. [Epub ahead of print] Review.

PMID:
24907149
[PubMed - as supplied by publisher]
Free Article
5.

Real-life experience with switching TNF-α inhibitors in ankylosing spondylitis.

Gulyas K, Bodnar N, Nagy Z, Szamosi S, Horvath A, Vancsa A, Vegh E, Szabo Z, Szucs G, Szekanecz Z, Szanto S.

Eur J Health Econ. 2014 May;15 Suppl 1:S93-100. doi: 10.1007/s10198-014-0598-0. Epub 2014 May 16.

PMID:
24832840
[PubMed - in process]
6.

Acceptability of less than perfect health states in rheumatoid arthritis: the patients' perspective.

Péntek M, Rojkovich B, Czirják L, Géher P, Keszthelyi P, Kovács A, Kovács L, Szabó Z, Szekanecz Z, Tamási L, Tóth ÁE, Ujfalussy I, Hevér NV, Strbák B, Baji P, Brodszky V, Gulácsi L.

Eur J Health Econ. 2014 May;15 Suppl 1:S73-82. doi: 10.1007/s10198-014-0596-2. Epub 2014 May 16.

PMID:
24832838
[PubMed - in process]
7.

Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison.

Baji P, Péntek M, Czirják L, Szekanecz Z, Nagy G, Gulácsi L, Brodszky V.

Eur J Health Econ. 2014 May;15 Suppl 1:S53-64. doi: 10.1007/s10198-014-0594-4. Epub 2014 May 16.

PMID:
24832836
[PubMed - in process]
Free PMC Article
8.

Biologics, cardiovascular effects and cancer.

Damjanov N, Nurmohamed MT, Szekanecz Z.

BMC Med. 2014 Mar 18;12:48. doi: 10.1186/1741-7015-12-48.

PMID:
24642038
[PubMed - in process]
Free PMC Article
9.

Visualization of DAS28, SDAI, and CDAI: the magic carpets of rheumatoid arthritis.

Futó G, Somogyi A, Szekanecz Z.

Clin Rheumatol. 2014 May;33(5):623-9. doi: 10.1007/s10067-014-2559-5. Epub 2014 Mar 6.

PMID:
24599677
[PubMed - in process]
10.

Disease activity after the discontinuation of biological therapy in inflammatory rheumatic diseases.

Kádár G, Balázs E, Soós B, Laduver A, Keszthelyi P, Szekanecz Z, Kovács L.

Clin Rheumatol. 2014 Mar;33(3):329-33. doi: 10.1007/s10067-014-2508-3. Epub 2014 Feb 5.

PMID:
24497172
[PubMed - in process]
11.

Follicular helper T cells in autoimmune diseases.

Papp G, Szabó K, Szekanecz Z, Zeher M.

Rheumatology (Oxford). 2014 Jul;53(7):1159-60. doi: 10.1093/rheumatology/ket434. Epub 2014 Jan 8. No abstract available.

PMID:
24402581
[PubMed - in process]
12.

Of mice and men: how animal models advance our understanding of T-cell function in RA.

Kobezda T, Ghassemi-Nejad S, Mikecz K, Glant TT, Szekanecz Z.

Nat Rev Rheumatol. 2014 Mar;10(3):160-70. doi: 10.1038/nrrheum.2013.205. Epub 2014 Jan 7.

PMID:
24394350
[PubMed - in process]
13.

[Systemic sclerosis and pregnancy. A review of the current literature].

Németh A, Szamosi S, Horváth A, Schönherr J, Nicksch E, Szekanecz Z, Szűcs G.

Z Rheumatol. 2014 Mar;73(2):175-9. doi: 10.1007/s00393-013-1267-x. German.

PMID:
24306839
[PubMed - in process]
14.

Microbiological profile of adenoid hypertrophy correlates to clinical diagnosis in children.

Szalmás A, Papp Z, Csomor P, Kónya J, Sziklai I, Szekanecz Z, Karosi T.

Biomed Res Int. 2013;2013:629607. doi: 10.1155/2013/629607. Epub 2013 Sep 23.

PMID:
24175295
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Rosuvastatin improves impaired endothelial function, lowers high sensitivity CRP, complement and immuncomplex production in patients with systemic sclerosis--a prospective case-series study.

Timár O, Szekanecz Z, Kerekes G, Végh J, Oláh AV, Nagy G, Csiki Z, Dankó K, Szamosi S, Németh Á, Soltész P, Szücs G.

Arthritis Res Ther. 2013;15(5):R105.

PMID:
24008003
[PubMed - in process]
Free PMC Article
16.

Treatment of ankylosing spondylitis with biologics and targeted physical therapy: positive effect on chest pain, diminished chest mobility, and respiratory function.

Gyurcsik Z, Bodnár N, Szekanecz Z, Szántó S.

Z Rheumatol. 2013 Dec;72(10):997-1004. doi: 10.1007/s00393-013-1240-8.

PMID:
23929243
[PubMed - in process]
17.

Peripheral blood derived gene panels predict response to infliximab in rheumatoid arthritis and Crohn's disease.

Mesko B, Poliska S, Váncsa A, Szekanecz Z, Palatka K, Hollo Z, Horvath A, Steiner L, Zahuczky G, Podani J, Nagy AL.

Genome Med. 2013 Jun 28;5(6):59. [Epub ahead of print]

PMID:
23809696
[PubMed - as supplied by publisher]
Free PMC Article
18.

Induction of response with etanercept-methotrexate therapy in patients with moderately active rheumatoid arthritis in Central and Eastern Europe in the PRESERVE study.

Pavelka K, Szekanecz Z, Damjanov N, Majdan M, Nasonov E, Mazurov V, Fabo T, Bananis E, Jones H, Szumski A, Tang B, Kotak S, Koenig AS, Vasilescu R.

Clin Rheumatol. 2013 Sep;32(9):1275-81. doi: 10.1007/s10067-013-2240-4. Epub 2013 May 11.

PMID:
23666316
[PubMed - indexed for MEDLINE]
19.

Differentially expressed epigenome modifiers, including aurora kinases A and B, in immune cells in rheumatoid arthritis in humans and mouse models.

Glant TT, Besenyei T, Kádár A, Kurkó J, Tryniszewska B, Gál J, Soós G, Szekanecz Z, Hoffmann G, Block JA, Katz RS, Mikecz K, Rauch TA.

Arthritis Rheum. 2013 Jul;65(7):1725-35. doi: 10.1002/art.37986.

PMID:
23653330
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Clinical course, prognosis, and causes of death in mixed connective tissue disease.

Hajas A, Szodoray P, Nakken B, Gaal J, Zöld E, Laczik R, Demeter N, Nagy G, Szekanecz Z, Zeher M, Szegedi G, Bodolay E.

J Rheumatol. 2013 Jul;40(7):1134-42. doi: 10.3899/jrheum.121272. Epub 2013 May 1.

PMID:
23637328
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk